NCX1 Is a Novel Target Gene for Hypoxia-Inducible Factor-1 in Ischemic Brain Preconditioning
Author(s) -
Valeria Valsecchi,
Giuseppe Pignataro,
Annalisa Del Prete,
Rossana Sirabella,
Carmela Matrone,
Francesca Boscia,
Antonella Scorziello,
Maria Josè Sisalli,
Elga Esposito,
Nicola Zambrano,
Gianfranco Di Renzo,
Lucio Annunziato
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.597583
Subject(s) - medicine , ischemic preconditioning , hypoxia (environmental) , ischemic stroke , hypoxia inducible factors , hypoxia inducible factor 1 , stroke (engine) , pharmacology , neuroscience , gene , cardiology , ischemia , transcription factor , genetics , oxygen , chemistry , organic chemistry , biology , mechanical engineering , engineering
The sodium-calcium exchanger-1 (NCX1) represents a key mediator for maintaining [Na(+)](i) and [Ca(2+)](i) homeostasis. Although changes in NCX1 protein and transcript expression have been detected during stroke, its transcriptional regulation is still unknown. Thus far, however, there is evidence that hypoxia-inducible factor-1 (HIF-1) is a nuclear factor required for transcriptional activation of several genes implicated in stroke. The main objective of this study was to investigate whether NCX1 gene might be a novel target of HIF-1 in the brain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom